<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/jcm14124385</dc:identifier><dc:language>eng</dc:language><dc:creator>Aguinagalde, Borja</dc:creator><dc:creator>Ferrer-Bonsoms, Juan A.</dc:creator><dc:creator>López, Iker</dc:creator><dc:creator>Lizarbe, Jon Ander</dc:creator><dc:creator>Fernandez-Monge, Arantza</dc:creator><dc:creator>Mainer, Maria</dc:creator><dc:creator>Embun, Raul</dc:creator><dc:creator>Zabaleta, Jon</dc:creator><dc:title>Recurrence Pattern of Left Upper Lobectomies and Trisegmentectomies: Systematic Review and Meta-Analysis</dc:title><dc:identifier>ART-2025-144647</dc:identifier><dc:description>Background: Surgical resection remains the standard treatment for early-stage non-small-cell lung cancer (NSCLC). Traditionally, lobectomy has been considered the procedure of choice; however, emerging evidence suggests that trisegmentectomy may offer comparable outcomes. This meta-analysis evaluates whether left upper lobe trisegmentectomy provides non-inferior or superior oncologic outcomes compared to left upper lobectomy, with particular attention to recurrence patterns. Methods: Following PRISMA guidelines, we included comparative studies evaluating left upper lobectomy versus trisegmentectomy. Outcomes assessed included recurrence (locoregional and distant), morbidity, and the length of hospital stay. A meta-analysis was conducted using the metabin function from the R meta package. Results: Of 14 identified articles, 9 met the inclusion criteria. No significant differences were observed in locoregional recurrence. However, distant recurrence was significantly lower in the trisegmentectomy group (OR 0.58; 95% CI 0.41–0.82). While overall morbidity showed no significant difference (OR 0.95), analysis of matched studies favored trisegmentectomy (OR 0.73; 95% CI 0.56–0.96). Hospital stay was significantly shorter in the trisegmentectomy group (OR –0.94; 95% CI –1.26 to –0.63). Conclusions: Trisegmentectomy and lobectomy exhibit distinct recurrence patterns, with lobectomy associated with a higher rate of distant recurrence. Trisegmentectomy may provide oncologic and perioperative advantages in appropriately selected patients. The systematic review and meta-analysis are registered in PROSPERO (registration number: CRD420251066445).</dc:description><dc:date>2025</dc:date><dc:source>http://zaguan.unizar.es/record/161968</dc:source><dc:doi>10.3390/jcm14124385</dc:doi><dc:identifier>http://zaguan.unizar.es/record/161968</dc:identifier><dc:identifier>oai:zaguan.unizar.es:161968</dc:identifier><dc:identifier.citation>Journal of Clinical Medicine 14, 12 (2025), 4385 [12 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>https://creativecommons.org/licenses/by/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>